EPV122 - Substance Use Disorders and Psychiatric Comorbidity

EPV122

 

Substance Use Disorders and Psychiatric Comorbidity

 

K. Taleb ^1,*, F. Laajili ², H. ballouk ¹, Z. Bencharfa ¹, F. el omari ¹

¹psychiatry, ²Arrazi hospital, salé, Morocco

 

Introduction: Substance use disorders (SUDs) are often associated with other mental disorders—psychotic, mood, or anxiety—complicating treatment and worsening clinical and social outcomes.

Objectives: To describe the main psychiatric comorbidities among patients with SUDs and examine their relationship with substance type.

Methods: A retrospective descriptive study based on clinical records of patients consulting for SUDs. Collected data included sociodemographic profile, substances used, psychiatric diagnoses, and treatments.

Results: Results (N = 102):

        - Gender: predominantly male (~90%).

        - Age: mostly 20–40 years.

        - Main substances: tobacco (85%), cannabis (70%), alcohol (56%).

        - Comorbid disorders: psychotic (45%), mood (30%), anxiety (15%), personality (10%).

        - Polysubstance use: >50% of patients.

        - Treatments: antipsychotics (79%), antidepressants (55%), anxiolytics (38%).

Conclusions: SUDs are commonly associated with severe psychiatric comorbidities. Systematic screening and a dual-diagnosis approach are key to enhancing prognosis and patient reintegration.

 

Disclosure of Interest: None Declared